Milan: Philogen negative
(Teleborsa) - The Developer of biopharmaceutical products for the treatment of life-threatening conditions is in the red with a -2.46% loss.Philogen's weekly trend is more sluggish than the benchmark's movements, showing a downswing performance in comparison to the related FTSE Italia Mid Cap index.
At present, the short-term scenario for Philogen anticipates a sharp rise towards a target price of 19.9 Euros. In the case of a healthy temporary correction the most immediate target would be the 19.75 level. However, we expect prices to climb to the 20.05 high.
These analyses are to be considered solely for information purposes and are not in any way intended to constitute financial advice, a solicitation of funds from the public or the promotion of any form of investment.
(Teleborsa Research Department)
(Teleborsa) 11-07-2024 09:35 AM